Avoiding First-Pass Metabolism: The Biopharmaceutical Advantage Fueling Adoption of Transdermal Systems.
One of the most significant pharmacological advantages that actively drives the demand and adoption of the **Transdermal Drug Delivery Systems Market** is its ability to bypass the hepatic first-pass metabolism. When a drug is taken orally, it is absorbed from the gastrointestinal tract and immediately transported via the portal vein to the liver, where a substantial portion of the active...
ไลค์
รัก
ยิ้ม
6
4 ความคิดเห็น 0 แชร์ 1899 ยอดวิว 0 รีวิว